Wallroth named CFO at Molecular

Molecular Insight Pharmaceuticals Inc. of Cambridge announced today the appointment of Donald E. Wallroth to the position of chief financial officer.

Molecular Insight is a biopharmaceutical company specializing in the emerging field of molecular medicine, applying innovations in the identification and targeting of disease at the molecular level.

Wallroth joins the company from the national life sciences practice of Tatum LLC, an Atlanta-based executive financial services firm, Molecular Insight said.
(By Chris Reidy, Globe staff)